“The Role of CD-19 Targeting Chimeric Antigen Receptor (CAR) T-Cell Therapy in Non-Hodgkin Lymphoma”. 2024. High Yield Medical Reviews 2 (2). https://doi.org/10.59707/hymrFHJX7726.